nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—ADRB1—Adrenoceptors—ADRA2C—attention deficit hyperactivity disorder	0.0649	0.0865	CbGpPWpGaD
Propafenone—SCN5A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0392	0.0523	CbGpPWpGaD
Propafenone—ADRB1—Adrenoceptors—ADRA2A—attention deficit hyperactivity disorder	0.0341	0.0454	CbGpPWpGaD
Propafenone—ADRB1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.023	0.0306	CbGpPWpGaD
Propafenone—ADRB1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0225	0.03	CbGpPWpGaD
Propafenone—Carvedilol—ADRA2C—attention deficit hyperactivity disorder	0.0204	0.174	CrCbGaD
Propafenone—Bopindolol—HTR1B—attention deficit hyperactivity disorder	0.0199	0.17	CrCbGaD
Propafenone—ADRB1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0193	0.0257	CbGpPWpGaD
Propafenone—ADRB1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0189	0.0252	CbGpPWpGaD
Propafenone—Phenoxybenzamine—ADRA2C—attention deficit hyperactivity disorder	0.0157	0.134	CrCbGaD
Propafenone—SCN5A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.0151	0.0201	CbGpPWpGaD
Propafenone—ADRB1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0136	0.0182	CbGpPWpGaD
Propafenone—ADRB1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0131	0.0175	CbGpPWpGaD
Propafenone—ADRB1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0127	0.0169	CbGpPWpGaD
Propafenone—ADRB1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0123	0.0163	CbGpPWpGaD
Propafenone—ADRB1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0121	0.0161	CbGpPWpGaD
Propafenone—ADRB1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0119	0.0159	CbGpPWpGaD
Propafenone—ADRB1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0115	0.0153	CbGpPWpGaD
Propafenone—ADRB1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0111	0.0148	CbGpPWpGaD
Propafenone—ADRB1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0107	0.0142	CbGpPWpGaD
Propafenone—ADRB1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.0106	0.0141	CbGpPWpGaD
Propafenone—CYP1A2—Methylation—COMT—attention deficit hyperactivity disorder	0.0104	0.0138	CbGpPWpGaD
Propafenone—ADRB1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0103	0.0137	CbGpPWpGaD
Propafenone—ADRB1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0101	0.0135	CbGpPWpGaD
Propafenone—ADRB1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.01	0.0133	CbGpPWpGaD
Propafenone—SCN5A—cardiovascular system—attention deficit hyperactivity disorder	0.00997	0.0757	CbGeAlD
Propafenone—ADRB1—forebrain—attention deficit hyperactivity disorder	0.0095	0.0721	CbGeAlD
Propafenone—ADRB1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00933	0.0124	CbGpPWpGaD
Propafenone—Carvedilol—ADRA2A—attention deficit hyperactivity disorder	0.0087	0.0741	CrCbGaD
Propafenone—KCNH2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00856	0.0114	CbGpPWpGaD
Propafenone—ADRB1—cardiovascular system—attention deficit hyperactivity disorder	0.00803	0.061	CbGeAlD
Propafenone—Atomoxetine—HTR1B—attention deficit hyperactivity disorder	0.00786	0.067	CrCbGaD
Propafenone—ADRB1—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.0078	0.0104	CbGpPWpGaD
Propafenone—ADRB1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00777	0.0104	CbGpPWpGaD
Propafenone—Propranolol—HTR1B—attention deficit hyperactivity disorder	0.00747	0.0636	CrCbGaD
Propafenone—KCNH2—forebrain—attention deficit hyperactivity disorder	0.00725	0.0551	CbGeAlD
Propafenone—SCN5A—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.0072	0.00958	CbGpPWpGaD
Propafenone—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.00716	0.061	CrCbGaD
Propafenone—Atomoxetine—SLC6A3—attention deficit hyperactivity disorder	0.0071	0.0605	CrCbGaD
Propafenone—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.00702	0.0598	CrCbGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00698	0.00929	CbGpPWpGaD
Propafenone—Phenoxybenzamine—ADRA2A—attention deficit hyperactivity disorder	0.00671	0.0571	CrCbGaD
Propafenone—ADRB1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00653	0.0087	CbGpPWpGaD
Propafenone—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00647	0.00862	CbGpPWpGaD
Propafenone—SCN5A—nervous system—attention deficit hyperactivity disorder	0.0064	0.0486	CbGeAlD
Propafenone—SCN5A—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00619	0.00824	CbGpPWpGaD
Propafenone—SCN5A—central nervous system—attention deficit hyperactivity disorder	0.00616	0.0468	CbGeAlD
Propafenone—KCNH2—cardiovascular system—attention deficit hyperactivity disorder	0.00613	0.0466	CbGeAlD
Propafenone—KCNH2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.006	0.00799	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00575	0.00766	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00575	0.00766	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00569	0.00758	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00558	0.00743	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00558	0.00743	CbGpPWpGaD
Propafenone—Atomoxetine—SLC6A4—attention deficit hyperactivity disorder	0.00531	0.0452	CrCbGaD
Propafenone—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00518	0.0069	CbGpPWpGaD
Propafenone—ADRB1—nervous system—attention deficit hyperactivity disorder	0.00515	0.0392	CbGeAlD
Propafenone—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.005	0.00665	CbGpPWpGaD
Propafenone—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00498	0.0379	CbGeAlD
Propafenone—ADRB1—central nervous system—attention deficit hyperactivity disorder	0.00496	0.0377	CbGeAlD
Propafenone—SCN5A—brain—attention deficit hyperactivity disorder	0.00489	0.0372	CbGeAlD
Propafenone—KCNH2—midbrain—attention deficit hyperactivity disorder	0.00479	0.0364	CbGeAlD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00443	0.0059	CbGpPWpGaD
Propafenone—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00442	0.0336	CbGeAlD
Propafenone—ADRB1—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00439	0.00585	CbGpPWpGaD
Propafenone—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00439	0.00584	CbGpPWpGaD
Propafenone—KCNH2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00438	0.00583	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00434	0.00578	CbGpPWpGaD
Propafenone—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00434	0.00578	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00433	0.00577	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00431	0.00574	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.0042	0.00559	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00418	0.00556	CbGpPWpGaD
Propafenone—Atomoxetine—HTR2A—attention deficit hyperactivity disorder	0.00408	0.0348	CrCbGaD
Propafenone—SCN5A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00406	0.00541	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00405	0.00539	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00401	0.00534	CbGpPWpGaD
Propafenone—ADRB1—brain—attention deficit hyperactivity disorder	0.00394	0.0299	CbGeAlD
Propafenone—KCNH2—nervous system—attention deficit hyperactivity disorder	0.00394	0.0299	CbGeAlD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0038	0.00506	CbGpPWpGaD
Propafenone—KCNH2—central nervous system—attention deficit hyperactivity disorder	0.00379	0.0288	CbGeAlD
Propafenone—KCNH2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00377	0.00502	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00372	0.00495	CbGpPWpGaD
Propafenone—KCNH2—cerebellum—attention deficit hyperactivity disorder	0.0037	0.0281	CbGeAlD
Propafenone—SCN5A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00367	0.00488	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00353	0.0047	CbGpPWpGaD
Propafenone—KCNH2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.0035	0.00466	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00342	0.00456	CbGpPWpGaD
Propafenone—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00318	0.0242	CbGeAlD
Propafenone—KCNH2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00312	0.00416	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00301	0.00401	CbGpPWpGaD
Propafenone—KCNH2—brain—attention deficit hyperactivity disorder	0.00301	0.0229	CbGeAlD
Propafenone—ADRB1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00289	0.00385	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00286	0.00381	CbGpPWpGaD
Propafenone—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00286	0.00381	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00283	0.00377	CbGpPWpGaD
Propafenone—CYP2C8—brain—attention deficit hyperactivity disorder	0.00275	0.0209	CbGeAlD
Propafenone—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00269	0.0204	CbGeAlD
Propafenone—KCNH2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00265	0.00353	CbGpPWpGaD
Propafenone—KCNH2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00264	0.00351	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00263	0.0035	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00262	0.00349	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00258	0.00343	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00245	0.00326	CbGpPWpGaD
Propafenone—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00244	0.0185	CbGeAlD
Propafenone—ADRB1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00244	0.00324	CbGpPWpGaD
Propafenone—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.0024	0.0182	CbGeAlD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00237	0.00315	CbGpPWpGaD
Propafenone—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00235	0.0178	CbGeAlD
Propafenone—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00235	0.00313	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00233	0.0031	CbGpPWpGaD
Propafenone—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00233	0.0031	CbGpPWpGaD
Propafenone—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00231	0.0176	CbGeAlD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.0023	0.00306	CbGpPWpGaD
Propafenone—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00226	0.0172	CbGeAlD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00225	0.003	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00221	0.00295	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00214	0.00285	CbGpPWpGaD
Propafenone—ABCB1—midbrain—attention deficit hyperactivity disorder	0.0021	0.016	CbGeAlD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0021	0.00279	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00203	0.0027	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00199	0.00266	CbGpPWpGaD
Propafenone—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00199	0.00265	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00197	0.00262	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00196	0.00261	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00187	0.00249	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00184	0.00244	CbGpPWpGaD
Propafenone—CYP2D6—brain—attention deficit hyperactivity disorder	0.00183	0.0139	CbGeAlD
Propafenone—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00182	0.00242	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00181	0.00241	CbGpPWpGaD
Propafenone—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00173	0.0131	CbGeAlD
Propafenone—ADRB1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00172	0.00229	CbGpPWpGaD
Propafenone—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00166	0.0126	CbGeAlD
Propafenone—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00164	0.00219	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00163	0.00218	CbGpPWpGaD
Propafenone—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00162	0.0123	CbGeAlD
Propafenone—ADRB1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0016	0.00213	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0016	0.00212	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00157	0.00209	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00155	0.00206	CbGpPWpGaD
Propafenone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00153	0.00204	CbGpPWpGaD
Propafenone—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00153	0.00204	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00152	0.00202	CbGpPWpGaD
Propafenone—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00152	0.00202	CbGpPWpGaD
Propafenone—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00151	0.00201	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0015	0.002	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0015	0.002	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00148	0.00198	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00145	0.00194	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.0014	0.00186	CbGpPWpGaD
Propafenone—ABCB1—brain—attention deficit hyperactivity disorder	0.00132	0.01	CbGeAlD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00131	0.00174	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.00131	0.00174	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00131	0.00174	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00129	0.00171	CbGpPWpGaD
Propafenone—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00126	0.00167	CbGpPWpGaD
Propafenone—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00125	0.00166	CbGpPWpGaD
Propafenone—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00124	0.00166	CbGpPWpGaD
Propafenone—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00124	0.00165	CbGpPWpGaD
Propafenone—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00124	0.00165	CbGpPWpGaD
Propafenone—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00123	0.00164	CbGpPWpGaD
Propafenone—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00123	0.00164	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00117	0.00156	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00111	0.00148	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00106	0.00142	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00106	0.00141	CbGpPWpGaD
Propafenone—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00105	0.0014	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00102	0.00136	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00101	0.00134	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000979	0.0013	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00097	0.00129	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000902	0.0012	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000881	0.00117	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000877	0.00117	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000873	0.00116	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000859	0.00114	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000858	0.00114	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000848	0.00113	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000842	0.00112	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000821	0.00109	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000819	0.00109	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000815	0.00109	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00081	0.00108	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000793	0.00106	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00079	0.00105	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000779	0.00104	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00077	0.00103	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000744	0.00099	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000717	0.000955	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000626	0.000833	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000595	0.000793	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000572	0.000762	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000553	0.000737	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000545	0.000726	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000526	0.0007	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00052	0.000693	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000514	0.000684	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000509	0.000678	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000502	0.000669	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000484	0.000644	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000468	0.000624	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00046	0.000613	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000455	0.000606	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000435	0.000579	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000432	0.000575	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000432	0.000575	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000425	0.000566	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000424	0.000564	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000395	0.000526	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000376	0.000501	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000376	0.000501	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00037	0.000493	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000354	0.000472	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000354	0.000472	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000351	0.000468	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000351	0.000468	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000349	0.000464	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000346	0.00046	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000345	0.00046	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000344	0.000458	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000336	0.000447	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000329	0.000438	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000324	0.000432	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000321	0.000428	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000301	0.0004	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.0003	0.0004	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.0003	0.0004	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000297	0.000395	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000295	0.000393	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000286	0.000381	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000283	0.000377	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000281	0.000374	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000275	0.000366	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00027	0.000359	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000267	0.000356	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	0.000262	0.000348	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00026	0.000346	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000252	0.000335	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00024	0.00032	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000232	0.000309	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000232	0.000309	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000229	0.000304	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000228	0.000304	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000228	0.000303	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000226	0.000301	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000215	0.000286	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000213	0.000284	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000213	0.000284	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000212	0.000282	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000211	0.000282	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000205	0.000273	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000185	0.000247	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000182	0.000242	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000181	0.000241	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000176	0.000235	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000175	0.000233	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000157	0.000209	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.00014	0.000187	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000139	0.000186	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	0.000112	0.000149	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	9.77e-05	0.00013	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	9.21e-05	0.000123	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	9.13e-05	0.000122	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	7.8e-05	0.000104	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	6.02e-05	8.02e-05	CbGpPWpGaD
